Etsuro Yamaguchi
Overview
Explore the profile of Etsuro Yamaguchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
1002
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Meguro A, Ishihara M, Petrek M, Yamamoto K, Takeuchi M, Mrazek F, et al.
Commun Biol
. 2020 Aug;
3(1):465.
PMID: 32826979
Sarcoidosis is a genetically complex systemic inflammatory disease that affects multiple organs. We present a GWAS of a Japanese cohort (700 sarcoidosis cases and 886 controls) with replication in independent...
12.
Tanaka H, Yamaguchi E, Asai N, Yokoi T, Nishimura M, Nakao H, et al.
Sarcoidosis Vasc Diffuse Lung Dis
. 2020 Jun;
36(2):141-147.
PMID: 32476947
Background: Development of reliable new biomarkers remains crucial to improve diagnosis and assessing disease activity in sarcoidosis. The objective of this study was to seek such markers from the gene...
13.
Nakata K, Sugi T, Kuroda K, Yoshizawa K, Takada T, Tazawa R, et al.
ERJ Open Res
. 2020 Feb;
6(1).
PMID: 32010720
Very recently, a modest but significant efficacy of granulocyte-macrophage colony-stimulating factor (GM-CSF) inhalation therapy for the treatment of mild to moderate autoimmune pulmonary alveolar proteinosis (aPAP) has been reported. As...
14.
Terasaki F, Azuma A, Anzai T, Ishizaka N, Ishida Y, Isobe M, et al.
Circ J
. 2019 Oct;
83(11):2329-2388.
PMID: 31597819
No abstract available.
15.
Tazawa R, Ueda T, Abe M, Tatsumi K, Eda R, Kondoh S, et al.
N Engl J Med
. 2019 Sep;
381(10):923-932.
PMID: 31483963
Background: Pulmonary alveolar proteinosis is a disease characterized by abnormal accumulation of surfactant in the alveoli. Most cases are autoimmune and are associated with an autoantibody against granulocyte-macrophage colony-stimulating factor...
16.
17.
Asai N, Kubo A, Suzuki S, Murotani K, Numanami H, Yoshikawa K, et al.
Cancer Invest
. 2019 Mar;
37(3):163-173.
PMID: 30907146
To clarify the prognostic impact of tumor-infiltrating effector regulatory T cells (eTregs) in non-small cell lung cancer (NSCLC), eTregs were evaluated by immunohistochemical detection of CCR4 and Foxp3 in 108...
18.
Kato T, Ito S, Tsuzuki T, Watanabe D, Kubo A, Yamaguchi E
Respirol Case Rep
. 2019 Mar;
7(4):e00412.
PMID: 30906559
Antibodies to transcriptional intermediary factor-1γ (TIF-1γ) are strongly associated with malignancy in patients with dermatomyositis but a relatively low risk for interstitial lung disease. We report the case of a...
19.
Tsukiyama I, Ando M, Tsukiyama S, Takeuchi M, Ejiri M, Kurose Y, et al.
Support Care Cancer
. 2019 Feb;
27(10):3749-3758.
PMID: 30710243
Purpose: Neurokinin-1 receptor antagonist (NKRA) is recommended to prevent chemotherapy-induced nausea and vomiting (CINV) in patients who receive highly or moderately emetogenic chemotherapy (HEC or MEC, respectively). We previously reported...
20.
Isobe Y, Ito S, Matsuda T, Iwano S, Uchida A, Takahashi N, et al.
Respir Physiol Neurobiol
. 2018 Dec;
261:1-8.
PMID: 30583069
The aim of this study was to examine long-term changes in pulmonary function and respiratory impedance (Zrs) as assessed by forced oscillation technique (FOT) of rheumatoid arthritis (RA)-related pulmonary disorders....